Compound class:
Synthetic organic
Comment: RP60556A is the most potent compound from the benzo[b]naphthyridones, a series of antibacterial compounds active against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) [1]. It was being developed as a topical treatment by Sanofi-Aventis but has been discontinued.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
7-fluoro-8-[4-(4-fluorophenyl)piperazin-1-yl]-1-methyl-4-oxopyrido[6,5-b]quinoline-3-carboxylic acid |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
RP60556A |
Other databases | |
ChEMBL Ligand | CHEMBL1183217 |
GtoPdb PubChem SID | 405560447 |
PubChem CID | 484065 |
Search Google for chemical match using the InChIKey | YYHFVZLNDMSUBV-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | YYHFVZLNDMSUBV |
UniChem Compound Search for chemical match using the InChIKey | YYHFVZLNDMSUBV-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YYHFVZLNDMSUBV-UHFFFAOYSA-N |